SHELBY HITES: Open Payments
NPI 1316373491 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,257 in 134 payments from 13 companies in 2025. Trend: 2023 $2,573 · 2024 $938 · 2025 $2,257
Food & beverage: $2,257
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 29 | $423 |
| Alkermes, Inc. | 15 | $386 |
| Otsuka America Pharmaceutical, Inc. | 21 | $367 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $204 |
| Axsome Therapeutics, Inc. | 15 | $192 |
| ABBVIE INC. | 14 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $144 |
| Lundbeck LLC | 5 | $101 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
Products named: Jornay PM, REXULTI, LYBALVI, TRINTELLIX, Auvelity, VRAYLAR, CAPLYTA, ARISTADA.
Industry payments across PA — which companies pay providers there.
